Ultragenyx | Company Profile
Contact Information
Industry & Market
Company Metrics
Funding Information
Headcount Distribution
By Department
Department Breakdown
Technology Stack
Analytics & Tracking
Development
Email & Communication
Keywords & Focus Areas
Ultragenyx
Overview
Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company based in Novato, California, founded in 2010. The organization specializes in developing and commercializing therapies for rare and ultra-rare genetic diseases. Established by Dr. Emil D. Kakkis, Ultragenyx seeks to address unmet medical needs for patient populations frequently underserved by larger pharmaceutical firms.
The company is known for innovative treatments, including enzyme replacement therapies, gene therapies, and antisense oligonucleotide therapies. Its product portfolio includes notable therapies such as Crysvita, which achieved significant revenue in 2023. Through strategic acquisitions, Ultragenyx has expanded its pipeline and enhanced capabilities in gene therapy research. The company actively engages with patient communities and caregivers to shape its development priorities, prioritizing corporate responsibility and integrating environmental, social, and governance principles in its operations.
Basic Information
| Industry | research |
|---|---|
| Founded | 2010 |
| Revenue | $590.7M |
| Headquarters | 60 Leveroni Court, Novato, California 94949, United States |
| Languages | English |
| Alexa Ranking | 464711 |
Contact Details
- Phone: +1 415-483-8800
- Website: ultragenyx.com
- LinkedIn: linkedin.com/company/ultragenyx
Key Focus Areas & Initiatives
- Rare disease & ultrarare disease research
- Enzyme replacement therapy development
- Gene therapies and antisense oligonucleotide platforms
- Patient advocacy and support programs
- Clinical trial transparency and management
- Biotech innovation in rare diseases
- Corporate responsibility and ESG initiatives
- Drug discovery and pipeline diversification
- Patient-centric approach to therapy development
- Strategic biotech growth and partnerships
- Commercialization of therapies for unmet medical needs
- Global expansion in biopharmaceutical markets
Technologies Used
- AI
- Akamai RUM
- Bootstrap Framework
- CloudFlare Hosting
- Cloudflare DNS
- Google Analytics
- Google Tag Manager
- Hotjar
- Microsoft Office 365
- Mimecast
- Mobile Friendly
- New Relic
- Outlook
- Remote
- Webflow
- WordPress.org
Community
